| Open Document File Size: 542,18 KBShare Result on Facebook
Company Forest Laboratories / / Country United States / / Currency pence / / Event FDA Phase / / IndustryTerm mg/mL oral solution / food / chemical / / MedicalCondition loss of consciousness / dementia / Lymphatic System Disorders / headache / Skin Disorders / seizures / Dizziness Headache Gastrointestinal System Constipation Vomiting Musculoskeletal System Back pain Psychiatric Disorders Confusion Somnolence Hallucination Respiratory System Coughing Dyspnea / Stevens Johnson syndrome / cardiac failure / leukopenia / coma / Hepatobiliary Disorders / AChE / Cardiac Disorders / bradycardia / hypersensitivity / restlessness / severe infections / visual hallucinations / hepatitis / constipation / Gastrointestinal Disorders / agranulocytosis / trials involving dementia / Seizures NAMENDA / Alzheimer’s disease / necrosis / disease / Urinary Disorders / neuronal necrosis / Carcinogenesis / severe dementia / neutropenia / vertigo / severe Alzheimer’s disease / seizure disorder / lethargy / vomiting / stupor / renal insufficiency / Psychiatric Disorders / vascular dementia / unsteady gait / pancreatitis / thrombocytopenia / thrombotic thrombocytopenic purpura / dizziness / renal tubular acidosis / overall dementia / diplopia / acute renal failure / pancytopenia / / Organization FDA / / Person Stevens Johnson / / / Product ranitidine / polyethylene glycol / sodium bicarbonate / cimetidine / Glucovance / talc / digoxin / NAMENDA / donepezil / glycine / sorbitol / glyburide / hydrochlorothiazide / nicotine / following / / ProvinceOrState Florida / / Technology Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NAMENDA safely and effectively. See full prescribing information for NAMENDA. ------------------------CONTRAINDICAT